Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-10-17
2006-10-17
Carlson, Karen Cochrane (Department: 1653)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
Reexamination Certificate
active
07122353
ABSTRACT:
The present invention provides for fusion proteins that act as targeted drug carries. The proteins are derived from molecules that possess natural drug-binding capabilities that are further engineered to target specific cell types, and optionally to have altered/improved drug binding characteristics. These fusion proteins are useful in, for example, delivery of chemotherapeutic compounds to cancer cells.
REFERENCES:
patent: 2002/0182671 (2002-12-01), Lal et al.
patent: 2005/0042753 (2005-02-01), Yang et al.
patent: WO 87/02061 (1987-04-01), None
patent: WO 95/03064 (1995-02-01), None
patent: WO 98/10795 (1998-03-01), None
patent: WO 01/53342 (2001-07-01), None
Aina et al., “Therapeutic cancer targeting peptides,”Pept. Sci.,66:184-199, 2002.
Martin et al., “Molecular basis of mitomycin C resistance in Streptomyces: structure and function of the MRD protein,”Structure, 10:933-942, 2002.
Shen et al., “Enediyne natural products: biosynthesis and prospect towards engineering novel antitumor agents,”Current Medicinal Chemistry, 10(1):1241-1253, 2003.
Sugiyama et al., “The 1.6-Å crystal structure of the copper(II)-bound bleomycin complexed with the bleomycin-binding protein from bleomycin-producing streptomyces verticillus,”J. Biol. Chem.,277(3):2311-2320, 2002.
Tanaka et al., “Solution structures of C-1027 apoprotein and its complex with the aromatized chromophore,”J. Mol. Biol.,309:267-283, 2001.
Thornson et al., “Enediyne biosynthesis and self-resistance: a progress report,”Bioorganic Chemistry, 27(2):172-188, 1999.
Sheldon et al., “Characterization of a mitomycin-binding drug resistance mechanism from the producing organism,streptomyces lavendulae,” J. Bacter.,179(5):1796-1804, 1997.
Fulbright & Jaworski
Rooke Agnes B.
Wisconsin Alumni Research Foundation
LandOfFree
Targeted carrier fusions for delivery of chemotherapeutic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeted carrier fusions for delivery of chemotherapeutic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted carrier fusions for delivery of chemotherapeutic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3641170